The landscape of dementia diagnosis has progressed significantly with the advent of advanced biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology many years prior to indicators emerge. Although these technological developments symbolize exceptional progress in understanding neurodegenerative disorders, they ha... https://posecic086xhq4.wikipresses.com/user